Infectious Disease Efficacy Evaluation
Mouse models, both wildtype and humanized, can be infected with specific pathogens such as new strains of viruses, drug-resistant bacteria, and invasive fungi, allowing researchers to closely observe pathobiology and immune system responses, leading to the discovery of targeted drugs. In drug development, mouse models allow for the preclinical evaluation of those potential drugs and assessment of their efficacy in reducing pathogen load, alleviating symptoms, and improving survival rates.
-
About Our Biosafety Laboratory
Our facility is equipped with a high-specification Biosafety Level 2 (BSL-2) laboratory. This laboratory has obtained authorization from local authorities, enabling us to legally and compliantly undertake operations involving various BSL-2 pathogens. Our BSL-2 laboratory adheres to strict safety standards and protocols to ensure the secure handling of these pathogens, providing a reliable environment for research and testing related to infectious diseases.
-
In vitro Drug Efficacy Evaluation
Our platform offers a wide range of professional and efficient services for the in vitro screening of antiviral, antibacterial, and antifungal drugs. Moreover, we offer the opportunity to collaborate in developing customized detection methods, ensuring that our services meet specific research and development needs.
-
In vivo Drug Dfficacy Evaluation
GemPharmatech offers comprehensive and reliable preclinical evaluation services for infectious disease therapeutics. We specialize in developing and applying tailored animal models to simulate a wide range of infectious diseases. Leveraging our extensive mouse resources, we select optimal models based on disease-specific mechanisms, enabling rigorous evaluation of small-molecule drugs, antibodies, vaccines, and novel treatment modalities.